There was no significant change in plasma HGF levels between baseline and day 8 (Wilcoxon signed-rank p = 0.545) or 15 (p = 0.860) during radiotherapy or between HCC versus ICC patients (Figure S1). This evidence concerns the gene HGF and intrahepatic cholangiocarcinoma.